Literature DB >> 12475975

Lack of tyrosine nitration by hypochlorous acid in the presence of physiological concentrations of nitrite. Implications for the role of nitryl chloride in tyrosine nitration in vivo.

Matthew Whiteman1, Jia Ling Siau, Barry Halliwell.   

Abstract

Elevated levels of reactive nitrogen species (RNS) such as peroxynitrite have been implicated in over 50 diverse human diseases as measured by the formation of the RNS biomarker 3-nitrotyrosine. Recently, an additional RNS was postulated to contribute to 3-nitrotyrosine formation in vivo; nitryl chloride formed from the reaction of nitrite and neutrophil myeloperoxidase-derived hypochlorous acid (HOCl). Whether nitryl chloride nitrates intracellular protein is unknown. Therefore, we exposed intact human HepG2 and SW1353 cells or cell lysates to HOCl and nitrite and examined each for 3-nitrotyrosine formation by: 1) Western blotting, 2) using a commercial 3-nitrotyrosine enzyme-linked immunosorbent assay kit, 3) flow cytometric analysis, and 4) confocal microscopic analysis. With each approach, no significant 3-nitrotyrosine formation was observed in either whole cells or cell lysates. However, substantial 3-nitrotyrosine was observed when peroxynitrite (100 microm) was added to cells or cell lysates. These data suggest that nitryl chloride formed from the reaction of nitrite with HOCl does not contribute to the elevated levels of 3-nitrotyrosine observed in human diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12475975     DOI: 10.1074/jbc.M211086200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Factors influencing protein tyrosine nitration--structure-based predictive models.

Authors:  Alexander S Bayden; Vasily A Yakovlev; Paul R Graves; Ross B Mikkelsen; Glen E Kellogg
Journal:  Free Radic Biol Med       Date:  2010-12-21       Impact factor: 7.376

2.  Nitrite, a reactive nitrogen species, protects human alpha-2-macroglobulin from halogenated oxidant, HOCl.

Authors:  M Wasim Khan; Ashreeb Naqshbandi; Haseeb Zubair; Haseeb Ahsan; Shakil A Khan; Fahim H Khan
Journal:  Protein J       Date:  2010-05       Impact factor: 2.371

Review 3.  Bioanalytical profile of the L-arginine/nitric oxide pathway and its evaluation by capillary electrophoresis.

Authors:  Dmitri Y Boudko
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-02-15       Impact factor: 3.205

4.  High-resolution mass spectrometry analysis of protein oxidations and resultant loss of function.

Authors:  Stephen Barnes; Erin M Shonsey; Shannon M Eliuk; David Stella; Kerri Barrett; Om P Srivastava; Helen Kim; Matthew B Renfrow
Journal:  Biochem Soc Trans       Date:  2008-10       Impact factor: 5.407

5.  Does lycopene offer human LDL any protection against myeloperoxidase activity?

Authors:  Poh Yeong Chew; Lucy Riley; Daniel L Graham; Khalid Rahman; Gordon M Lowe
Journal:  Mol Cell Biochem       Date:  2011-10-11       Impact factor: 3.396

Review 6.  Elucidating mechanisms of chlorine toxicity: reaction kinetics, thermodynamics, and physiological implications.

Authors:  Giuseppe L Squadrito; Edward M Postlethwait; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-06-04       Impact factor: 5.464

7.  Angiotensin II decreases nitric oxide synthase 3 expression via nitric oxide and superoxide in the thick ascending limb.

Authors:  Vanesa D Ramseyer; Jeffrey L Garvin
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

8.  Reactive nitrogen species scavenging, rather than nitric oxide inhibition, protects from articular cartilage damage in rat zymosan-induced arthritis.

Authors:  Mirna Marques Bezerra; Susan D Brain; Stan Greenacre; Selma Maria Bezerra Jerônimo; Liana Batista de Melo; Julie Keeble; Francisco Airton Castro da Rocha
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

9.  Nitric oxide, oxidants, and protein tyrosine nitration.

Authors:  Rafael Radi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-12       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.